Market Cap 20.46B
Revenue (ttm) 6.07B
Net Income (ttm) 660.30M
EPS (ttm) N/A
PE Ratio 21.38
Forward PE 20.59
Profit Margin 10.87%
Debt to Equity Ratio 0.92
Volume 1,150,300
Avg Vol 1,804,170
Day's Range N/A - N/A
Shares Out 117.49M
Stochastic %K 52%
Beta 1.30
Analysts Strong Sell
Price Target $207.77

Company Profile

Equifax Inc. operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that that assist them in complying with and autom...

Industry: Consulting Services
Sector: Industrials
Phone: 404 885 8000
Address:
1550 Peachtree Street, NW, Atlanta, United States
PenkeInvesting
PenkeInvesting Jul. 25 at 3:59 PM
Fundamental analysis of $EFX (EQUIFAX INC) based on financial data and reported results. #EFX #EQUIFAX
0 · Reply
BrooksMarket
BrooksMarket Jul. 21 at 6:39 PM
$EFX delivered a solid Q2 earnings beat, but weaker-than-expected guidance overshadowed the results. • Revenue: $1.70B, up 11% YoY, above expectations • Adjusted EPS: $2.25, up 13% YoY, also ahead of estimates • AI-driven cost savings target doubled to $150M • Returned $366M to shareholders However, Q3 adjusted EPS guidance of $2.15–$2.25 came in below the Street consensus of roughly $2.26. Management also warned that higher interest rates continue to weigh on mortgage originations, with housing-related demand expected to remain soft through the second half of the year. The market is looking beyond the strong quarter. While cost controls and diversified businesses supported Q2, investors are focused on the delayed recovery in the mortgage segment, which remains a key driver of Equifax's long-term valuation. That explains why the stock is trading lower despite the earnings beat.
0 · Reply
topstockalerts
topstockalerts Jul. 21 at 5:53 PM
Equifax – Shares of the credit bureau dropped 7%. Equifax issued third-quarter guidance that disappointed Wall Street, calling for adjusted earnings of $2.15 to $2.25 per share on revenue of $1.68 billion to $1.71 billion. The FactSet consensus anticipated $2.26 per share in earnings and $1.71 billion in revenue $EFX
0 · Reply
flychicken1991
flychicken1991 Jul. 21 at 3:20 PM
$EFX Negative (89%): shares are pressured because weaker guidance lowers expected future earnings and cash flow, outweighing the backward-looking quarterly beat and prompting a reported 7% price decline. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/95c894ed906a2c68?utm_source=stocktwits&utm_medium=story_url
0 · Reply
EarningsInsider
EarningsInsider Jul. 21 at 2:46 PM
https://www.marketbeat.com/earnings/reports/2026-7-21-equifax-inc-stock/ $EFX Equifax Earnings Transcript
0 · Reply
BullcaseDan
BullcaseDan Jul. 21 at 1:44 PM
$EFX Joseph Carlson still holds this or quietly removed from the portfolio already?
0 · Reply
robertdollar
robertdollar Jul. 21 at 1:31 PM
$EFX love this dip.
0 · Reply
Muktar65
Muktar65 Jul. 21 at 1:29 PM
$EFX they guided with the range if you read between the lines
0 · Reply
DonCorleone77
DonCorleone77 Jul. 21 at 1:12 PM
$TSM $EFX $CALX $DHR $NOC PRE-MARKET MOVERS: Currently Higher After Earnings: - 3M (MMM) up 6.7% - Novartis (NVS) up 3.1% - Charles Schwab (SCHW) up 2.6% - General Motors (GM) up 1.1% - D.R. Horton (DHI) up 1.3% Currently Also Higher: - Nebius (NBIS) up 7.6% after Nvidia (NVDA) disclosed a 9.3% stake in the company - TSMC (TSM) up 3.8% after Nikkei Asia reported TSMC plans to raise chipmaking prices by up to 10% from 2027 to offset rising costs Currently Lower After Earnings: - Equifax (EFX) down 12.9% - Calix (CALX) down 8.9% - Danaher (DHR) down 15.0% - Northrop Grumman (NOC) down 4.8% - Steel Dynamics (STLD) down 0.3% Currently Also Lower: - Agios Pharmaceuticals (AGIO) down 12.8% after announcing it has decided not to advance tebapivat in sickle cell disease following trial results.
0 · Reply
Muktar65
Muktar65 Jul. 21 at 1:04 PM
$EFX beat this quarter top and bottom line and guidance within forecast narrowed its earnings and revenue outlook for the full year after its profit fell despite higher revenue in the latest completed quarter. The credit-reporting bureau on Tuesday said it now expects $6.71 billion to $6.78 billion in revenue for the full year, and adjusted earnings of $8.39 to $8.69 a share. It had previously set targets for $6.69 billion to $6.81 billion in revenue and adjusted earnings of $8.34 to $8.74 a share. In the current quarter, the company is targeting revenue of $1.68 billion to $1.71 billion. Analysts polled by FactSet had been projecting $1.71 billion. Adjusted earnings should hit $2.15 to $2.25 Stripping out one-time items, adjusted earnings were $2.25 a share. Analysts polled by FactSet had been expecting $ 2.20 a share. Revenue meanwhile was up 11% at $1.7 billion, topping analyst estimates. The company pulled in more mortgage revenue and saw strength across its business units.
0 · Reply
Latest News on EFX
Equifax price target lowered to $210 from $225 at BofA

2026-07-22T12:55:44.000Z - 13 days ago

Equifax price target lowered to $210 from $225 at BofA


Equifax price target lowered to $194 from $222 at RBC Capital

2026-07-22T11:15:11.000Z - 13 days ago

Equifax price target lowered to $194 from $222 at RBC Capital


Equifax price target lowered to $212 from $220 at Wells Fargo

2026-07-22T11:05:13.000Z - 13 days ago

Equifax price target lowered to $212 from $220 at Wells Fargo


Equifax price target lowered to $232 from $245 at Baird

2026-07-22T10:40:56.000Z - 14 days ago

Equifax price target lowered to $232 from $245 at Baird


Equifax price target lowered to $200 from $215 at Barclays

2026-07-22T09:20:11.000Z - 14 days ago

Equifax price target lowered to $200 from $215 at Barclays


Equifax Earnings Call Transcript: Q2 2026

Jul 21, 2026, 8:30 AM EDT - 14 days ago

Equifax Earnings Call Transcript: Q2 2026


Equifax Earnings release: Q2 2026

Jul 21, 2026, 8:30 AM EDT - 14 days ago

Equifax Earnings release: Q2 2026


Equifax Slides: Q2 2026

Jul 21, 2026, 8:30 AM EDT - 14 days ago

Equifax Slides: Q2 2026


Equifax Quarterly report: Q2 2026

Jul 21, 2026, 8:30 AM EDT - 14 days ago

Equifax Quarterly report: Q2 2026


Equifax Shareholder letter: Q2 2026

Jul 21, 2026, 8:30 AM EDT - 14 days ago

Equifax Shareholder letter: Q2 2026


Equifax reports Q2 adjusted EPS $2.25, consensus $2.20

2026-07-21T10:45:29.000Z - 15 days ago

Equifax reports Q2 adjusted EPS $2.25, consensus $2.20


Equifax sees Q3 adjusted EPS $2.15-$2.25, consensus $2.27

2026-07-21T10:45:23.000Z - 15 days ago

Equifax sees Q3 adjusted EPS $2.15-$2.25, consensus $2.27


Equifax Transcript: M&A announcement

Jul 7, 2026, 8:30 AM EDT - 4 weeks ago

Equifax Transcript: M&A announcement


Equifax Slides: M&A announcement

Jul 7, 2026, 8:30 AM EDT - 4 weeks ago

Equifax Slides: M&A announcement


Equifax Press release: M&A announcement

Jul 7, 2026, 8:30 AM EDT - 4 weeks ago

Equifax Press release: M&A announcement


Equifax price target lowered to $210 from $222 at Mizuho

2026-07-02T13:40:28.000Z - 4 weeks ago

Equifax price target lowered to $210 from $222 at Mizuho


Equifax price target raised to $220 from $215 at UBS

2026-07-02T12:50:43.000Z - 4 weeks ago

Equifax price target raised to $220 from $215 at UBS


Equifax adds 39 new global patents in first half of 2026

2026-06-30T11:50:15.000Z - 5 weeks ago

Equifax adds 39 new global patents in first half of 2026


U.S. Consumer Debt Hits $18.19 Trillion in Q1 2026

May 28, 2026, 7:45 AM EDT - 2 months ago

U.S. Consumer Debt Hits $18.19 Trillion in Q1 2026


Enerflex Ltd. Publishes 2026 Investor Update Presentation

May 27, 2026, 6:00 AM EDT - 2 months ago

Enerflex Ltd. Publishes 2026 Investor Update Presentation

EFXT


Equifax and GBG Expand Global Partnership

May 20, 2026, 7:45 AM EDT - 2 months ago

Equifax and GBG Expand Global Partnership


Equifax Board of Directors Declares Quarterly Dividend

May 7, 2026, 1:10 PM EDT - 3 months ago

Equifax Board of Directors Declares Quarterly Dividend


Equifax Transcript: AGM 2026

May 7, 2026, 9:00 AM EDT - 3 months ago

Equifax Transcript: AGM 2026


Enerflex Ltd. Announces Election of Directors

May 6, 2026, 8:53 PM EDT - 3 months ago

Enerflex Ltd. Announces Election of Directors

EFXT


Equifax Credits AI Tools for Record $1.6 Billion Quarter

Apr 21, 2026, 1:22 PM EDT - 3 months ago

Equifax Credits AI Tools for Record $1.6 Billion Quarter


Equifax Earnings Call Transcript: Q1 2026

Apr 21, 2026, 8:30 AM EDT - 3 months ago

Equifax Earnings Call Transcript: Q1 2026


Equifax Earnings release: Q1 2026

Apr 21, 2026, 8:30 AM EDT - 3 months ago

Equifax Earnings release: Q1 2026


Equifax Slides: Q1 2026

Apr 21, 2026, 8:30 AM EDT - 3 months ago

Equifax Slides: Q1 2026


Equifax Quarterly report: Q1 2026

Apr 21, 2026, 8:30 AM EDT - 3 months ago

Equifax Quarterly report: Q1 2026


Equifax Shareholder letter: Q1 2026

Apr 21, 2026, 8:30 AM EDT - 3 months ago

Equifax Shareholder letter: Q1 2026


First-Party Fraud Rises Amidst Economic Pressures

Apr 15, 2026, 6:00 AM EDT - 4 months ago

First-Party Fraud Rises Amidst Economic Pressures


Equifax Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 4 months ago

Equifax Proxy statement: Proxy filing


Equifax Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 4 months ago

Equifax Proxy statement: Proxy filing


Equifax Releases 2025 Security Annual Report

Mar 18, 2026, 7:45 AM EDT - 4 months ago

Equifax Releases 2025 Security Annual Report


Equifax Proxy statement: Proxy Filing

Mar 17, 2026, 8:00 AM EDT - 5 months ago

Equifax Proxy statement: Proxy Filing


Equifax Announces Participation in March Investor Conferences

Mar 3, 2026, 4:20 PM EST - 5 months ago

Equifax Announces Participation in March Investor Conferences


Canadians Feel Vulnerable about Scams and Rising Fraud Threats

Mar 3, 2026, 6:00 AM EST - 5 months ago

Canadians Feel Vulnerable about Scams and Rising Fraud Threats


Equifax Board of Directors Authorizes 12% Dividend Increase

Feb 25, 2026, 4:15 PM EST - 5 months ago

Equifax Board of Directors Authorizes 12% Dividend Increase


Equifax Earnings Call Transcript: Q4 2025

Feb 4, 2026, 8:30 AM EST - 6 months ago

Equifax Earnings Call Transcript: Q4 2025


Equifax Annual report: Q4 2025

Feb 4, 2026, 8:30 AM EST - 6 months ago

Equifax Annual report: Q4 2025


Equifax Shareholder letter: Q4 2025

Feb 4, 2026, 8:30 AM EST - 6 months ago

Equifax Shareholder letter: Q4 2025


Equifax Earnings release: Q4 2025

Feb 4, 2026, 8:30 AM EST - 6 months ago

Equifax Earnings release: Q4 2025


Equifax Slides: Q4 2025

Feb 4, 2026, 8:30 AM EST - 6 months ago

Equifax Slides: Q4 2025


Equifax Revenue Rises Despite Weak Hiring, Mortgage Markets

Feb 4, 2026, 6:56 AM EST - 6 months ago

Equifax Revenue Rises Despite Weak Hiring, Mortgage Markets


Equifax Launches Employment Insights Solutions for Auto Dealers

Jan 28, 2026, 4:20 PM EST - 6 months ago

Equifax Launches Employment Insights Solutions for Auto Dealers


Equifax Introduces Enhanced Synthetic Identity Fraud Detection

Jan 23, 2026, 7:45 AM EST - 6 months ago

Equifax Introduces Enhanced Synthetic Identity Fraud Detection


PenkeInvesting
PenkeInvesting Jul. 25 at 3:59 PM
Fundamental analysis of $EFX (EQUIFAX INC) based on financial data and reported results. #EFX #EQUIFAX
0 · Reply
BrooksMarket
BrooksMarket Jul. 21 at 6:39 PM
$EFX delivered a solid Q2 earnings beat, but weaker-than-expected guidance overshadowed the results. • Revenue: $1.70B, up 11% YoY, above expectations • Adjusted EPS: $2.25, up 13% YoY, also ahead of estimates • AI-driven cost savings target doubled to $150M • Returned $366M to shareholders However, Q3 adjusted EPS guidance of $2.15–$2.25 came in below the Street consensus of roughly $2.26. Management also warned that higher interest rates continue to weigh on mortgage originations, with housing-related demand expected to remain soft through the second half of the year. The market is looking beyond the strong quarter. While cost controls and diversified businesses supported Q2, investors are focused on the delayed recovery in the mortgage segment, which remains a key driver of Equifax's long-term valuation. That explains why the stock is trading lower despite the earnings beat.
0 · Reply
topstockalerts
topstockalerts Jul. 21 at 5:53 PM
Equifax – Shares of the credit bureau dropped 7%. Equifax issued third-quarter guidance that disappointed Wall Street, calling for adjusted earnings of $2.15 to $2.25 per share on revenue of $1.68 billion to $1.71 billion. The FactSet consensus anticipated $2.26 per share in earnings and $1.71 billion in revenue $EFX
0 · Reply
flychicken1991
flychicken1991 Jul. 21 at 3:20 PM
$EFX Negative (89%): shares are pressured because weaker guidance lowers expected future earnings and cash flow, outweighing the backward-looking quarterly beat and prompting a reported 7% price decline. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/95c894ed906a2c68?utm_source=stocktwits&utm_medium=story_url
0 · Reply
EarningsInsider
EarningsInsider Jul. 21 at 2:46 PM
https://www.marketbeat.com/earnings/reports/2026-7-21-equifax-inc-stock/ $EFX Equifax Earnings Transcript
0 · Reply
BullcaseDan
BullcaseDan Jul. 21 at 1:44 PM
$EFX Joseph Carlson still holds this or quietly removed from the portfolio already?
0 · Reply
robertdollar
robertdollar Jul. 21 at 1:31 PM
$EFX love this dip.
0 · Reply
Muktar65
Muktar65 Jul. 21 at 1:29 PM
$EFX they guided with the range if you read between the lines
0 · Reply
DonCorleone77
DonCorleone77 Jul. 21 at 1:12 PM
$TSM $EFX $CALX $DHR $NOC PRE-MARKET MOVERS: Currently Higher After Earnings: - 3M (MMM) up 6.7% - Novartis (NVS) up 3.1% - Charles Schwab (SCHW) up 2.6% - General Motors (GM) up 1.1% - D.R. Horton (DHI) up 1.3% Currently Also Higher: - Nebius (NBIS) up 7.6% after Nvidia (NVDA) disclosed a 9.3% stake in the company - TSMC (TSM) up 3.8% after Nikkei Asia reported TSMC plans to raise chipmaking prices by up to 10% from 2027 to offset rising costs Currently Lower After Earnings: - Equifax (EFX) down 12.9% - Calix (CALX) down 8.9% - Danaher (DHR) down 15.0% - Northrop Grumman (NOC) down 4.8% - Steel Dynamics (STLD) down 0.3% Currently Also Lower: - Agios Pharmaceuticals (AGIO) down 12.8% after announcing it has decided not to advance tebapivat in sickle cell disease following trial results.
0 · Reply
Muktar65
Muktar65 Jul. 21 at 1:04 PM
$EFX beat this quarter top and bottom line and guidance within forecast narrowed its earnings and revenue outlook for the full year after its profit fell despite higher revenue in the latest completed quarter. The credit-reporting bureau on Tuesday said it now expects $6.71 billion to $6.78 billion in revenue for the full year, and adjusted earnings of $8.39 to $8.69 a share. It had previously set targets for $6.69 billion to $6.81 billion in revenue and adjusted earnings of $8.34 to $8.74 a share. In the current quarter, the company is targeting revenue of $1.68 billion to $1.71 billion. Analysts polled by FactSet had been projecting $1.71 billion. Adjusted earnings should hit $2.15 to $2.25 Stripping out one-time items, adjusted earnings were $2.25 a share. Analysts polled by FactSet had been expecting $ 2.20 a share. Revenue meanwhile was up 11% at $1.7 billion, topping analyst estimates. The company pulled in more mortgage revenue and saw strength across its business units.
0 · Reply
The_Duck
The_Duck Jul. 21 at 1:03 PM
$EFX this again
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jul. 21 at 12:27 PM
$EFX Q2 '26 Earnings Results & Recap Equifax expects Q3 2026 reported revenue between $1.680 billion and $1.710 billion, with full year 2026 reported revenue ranging from $6.710 billion to $6.780 billion and adjusted EPS from $8.39 to $8.69.
0 · Reply
briefingcom
briefingcom Jul. 21 at 12:16 PM
$EFX: Equifax (-11.1%) beat EPS expectations by $0.05, reported revenues in-line, guided Q3 EPS below consensus with revenues in-line, and guided FY26 revenues and EPS in-line. The company signed an agreement to acquire Círculo de Crédito.
0 · Reply
2big2fail2018
2big2fail2018 Jul. 21 at 11:56 AM
$EFX tank
0 · Reply
1986iamwallstreet
1986iamwallstreet Jul. 21 at 11:04 AM
$EFX Equifax Sees Q3 Adj EPS $2.15-$2.25 vs $2.26 Est; Sees Sales $1.680B-$1.710B vs $1.711B Est 🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸
0 · Reply
Estimize
Estimize Jul. 21 at 10:00 AM
$EFX reported - EPS and - revenue for Q2. http://www.estimize.com/intro/efx?chart=historical&metric_name=eps&utm_content=EFX&utm_medium=act
0 · Reply
lousyjets
lousyjets Jul. 20 at 6:28 PM
$PLTR Few other names I am big on $NOW $EFX
0 · Reply
jwar1045
jwar1045 Jul. 14 at 12:26 PM
$EFX totally agree stock will go up once Begor announces his departure. Made over $100MILLION ++ for a 3.5% CAGR since his arrival in 2018.
0 · Reply
Mipel
Mipel Jul. 14 at 8:35 AM
$EFX http://Investing.com - Eurozone government bond yields climbed on Tuesday, with short-term debt taking the brunt of the selling, as escalating tensions in the Middle East and hawkish central bank rhetoric pushed investors to price in higher interest rates for longer.,,,
0 · Reply
Mipel
Mipel Jul. 13 at 12:35 PM
$EFX ….http://Investing.com - Chip stocks around the world fell sharply on Monday, led by a one-day record drop in SK Hynix shares, as investors weighed a fresh escalation in Middle East tensions alongside growing concerns about the value of artificial intelligence-related stocks.
0 · Reply
marketmaker79
marketmaker79 Jul. 10 at 7:00 AM
$EFX This company is dead money, retest 2022 lows next
0 · Reply
Estimize
Estimize Jul. 9 at 10:03 PM
Wall St is expecting 2.20 EPS for $EFX Q2 [Reporting 07/22 BMO] http://www.estimize.com/intro/efx?chart=historical&metric_name=eps&utm_cont
0 · Reply